Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience

Journal of Child Neurology
Manon HachéKathie M Bishop

Abstract

Nusinersen (ISIS-SMNRx or ISIS 396443) is an antisense oligonucleotide drug administered intrathecally to treat spinal muscular atrophy. We summarize lumbar puncture experience in children with spinal muscular atrophy during a phase 1 open-label study of nusinersen and its extension. During the studies, 73 lumbar punctures were performed in 28 patients 2 to 14 years of age with type 2/3 spinal muscular atrophy. No complications occurred in 50 (68%) lumbar punctures; in 23 (32%) procedures, adverse events were attributed to lumbar puncture. Most common adverse events were headache (n = 9), back pain (n = 9), and post-lumbar puncture syndrome (n = 8). In a subgroup analysis, adverse events were more frequent in older children, children with type 3 spinal muscular atrophy, and with a 21- or 22-gauge needle compared to a 24-gauge needle or smaller. Lumbar punctures were successfully performed in children with spinal muscular atrophy; lumbar puncture-related adverse event frequency was similar to that previously reported in children.

References

Aug 1, 1995·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·S K SharmaE R Herrera
Apr 1, 1996·Neurobiology of Disease·T O Crawford, C A Pardo
Mar 10, 2001·Medical and Pediatric Oncology·G LjungmanA Kreuger
Jun 24, 2003·AJR. American Journal of Roentgenology·Ursula Kiechl-KohlendorferIngmar Gassner
Oct 23, 2003·British Journal of Anaesthesia·D K Turnbull, D B Shepherd
Aug 3, 2006·Pediatrics·Agustín Molina, Jaime Fons
Aug 26, 2006·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Amin AminiDouglas L Brockmeyer
Nov 14, 2006·Postgraduate Medical Journal·S V AhmedE Jude
Sep 1, 2007·Journal of Child Neurology·Barry S Russman
Sep 22, 2007·AJNR. American Journal of Neuroradiology·B L KochJ C Egelhoff
Mar 29, 2008·American Journal of Human Genetics·Yimin HuaAdrian R Krainer
Jun 24, 2008·Lancet·Mitchell R Lunn, Ching H Wang
Dec 17, 2008·Paediatric Anaesthesia·Seza Apiliogullari, Ates Duman
Jan 17, 2009·AJNR. American Journal of Neuroradiology·S D YuA J Johnson
Nov 10, 2009·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Wai H Ng, James M Drake
Nov 17, 2009·Developmental Medicine and Child Neurology·Neil Gordon
Dec 18, 2009·Paediatric Anaesthesia·Seza ApiliogullariIsak Akillioglu
Apr 21, 2010·Pediatrics·Alyssa AboKaren Santucci
Jun 12, 2012·Archives of Disease in Childhood. Fetal and Neonatal Edition·Selim ÖncelMüge Alvur
Jan 16, 2013·Molecular Pharmaceutics·Mikhail I PapisovKimberley S Gannon
Nov 6, 2013·The Journal of Emergency Medicine·William Bonadio
Apr 30, 2014·The Journal of Emergency Medicine·Stephen Kim, David K Adler
Apr 22, 2015·JAMA : the Journal of the American Medical Association·Bruce M PsatyRuss B Altman

❮ Previous
Next ❯

Citations

Jun 12, 2016·Nucleic Acids Research·Mallory A Havens, Michelle L Hastings
Jul 28, 2016·Neuromuscular Disorders : NMD·Joseph K BurnsRobin J Parks
Nov 4, 2016·Nature Reviews. Drug Discovery·Masayuki Matsui, David R Corey
Sep 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·Suzan M HammondMatthew J A Wood
Nov 12, 2016·Trends in Pharmacological Sciences·Richard M O'ConnorJohn F Cryan
Feb 17, 2017·Biochemistry·Mia K MihailovicLydia M Contreras
Mar 1, 2017·Nature Biotechnology·Olga Khorkova, Claes Wahlestedt
Mar 1, 2017·Nature Biotechnology·Steven F Dowdy
Apr 5, 2017·American Journal of Medical Genetics. Part a·Felicity K BoardmanFrances E Griffiths
May 4, 2017·Gene Therapy·N M P King, C E Bishop
Dec 28, 2016·Annals of Neurology·Michelle A FarrarMatthew C Kiernan
Jun 22, 2017·Journal of Neurology·Ingrid E C VerhaartHanns Lochmüller
Jun 24, 2017·Gene Therapy·K Talbot, E F Tizzano
Feb 10, 2018·Nature Reviews. Neurology·Ewout J N GroenThomas H Gillingwater
Jun 13, 2017·Genes·Katharina E MeijboomGraham McClorey
Feb 24, 2018·International Journal of Molecular Sciences·Chi-Ming WongMabel Yin-Chun Yau
Dec 15, 2017·Nucleic Acids Research·Xiulong Shen, David R Corey
Nov 5, 2017·Der Nervenarzt·K VillW Müller-Felber
Aug 30, 2017·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Durgesh TiwariChristina Gross
Jul 17, 2018·The Annals of Pharmacotherapy·Melanie K ClabornBrooke L Gildon
Mar 20, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Michelle A FarrarMonique M Ryan
Nov 22, 2018·Journal of Neurology·Claudia D WursterTugrul Kocak
Apr 5, 2019·Assistive Technology : the Official Journal of RESNA·Laura J BallSally Evans
Dec 23, 2017·Frontiers in Molecular Neuroscience·Andrew P Tosolini, James N Sleigh
Dec 7, 2018·Biological & Pharmaceutical Bulletin·Yuya Hayashi, Hirofumi Jono
Feb 2, 2020·The Cochrane Database of Systematic Reviews·Renske I WadmanAlexander Fje Vrancken
Jul 15, 2018·Neurology·Aravindhan VeerapandiyanEmma Ciafaloni
Nov 22, 2019·Neurology. Clinical Practice·Carla D ZingarielloElizabeth A Kichula
Mar 24, 2020·Nucleic Acid Therapeutics·Viet Q ChauV Vinod Mootha
Feb 15, 2018·The New England Journal of Medicine·Eugenio MercuriUNKNOWN CHERISH Study Group
Jul 9, 2020·Medicinal Research Reviews·Maria Zakharova
Feb 1, 2020·Annual Review of Genomics and Human Genetics·Brunhilde WirthNatalia Mendoza-Ferreira
May 10, 2018·Arquivos de neuro-psiquiatria·Umbertina Conti Reed, Edmar Zanoteli
Aug 26, 2018·Nature Reviews. Neurology·Felix NitschkeBerge A Minassian
Apr 2, 2020·Yonsei Medical Journal·Qing Li

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligonucleotide
sedation
SMA

Clinical Trials Mentioned

NCT01494701
NCT01780246

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.